Tourmaline Bio (TRML) News Today $15.99 -0.55 (-3.33%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRML Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Tourmaline Bio, Inc. (NASDAQ:TRML) Receives $49.33 Average Price Target from AnalystsJune 27 at 2:37 AM | americanbankingnews.comTRML - Tourmaline Bio Inc Dividends - MorningstarJune 26, 2025 | morningstar.comMTRML - Tourmaline Bio Inc Executives - MorningstarJune 24, 2025 | morningstar.comMTourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Rating of "Buy" from BrokeragesJune 24, 2025 | marketbeat.comCantor Fitzgerald Weighs in on Tourmaline Bio FY2026 EarningsJune 11, 2025 | marketbeat.comTwo Sigma Investments LP Sells 21,904 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)June 10, 2025 | marketbeat.comTourmaline Bio Elects Directors and Ratifies AuditorJune 6, 2025 | tipranks.comTourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by Bank of America Corp DEJune 6, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Trading Up 7.2% - Here's What HappenedJune 5, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of "Buy" from BrokeragesMay 31, 2025 | marketbeat.comH.C. Wainwright maintains $50 target on Tourmaline Bio stockMay 29, 2025 | uk.investing.comH.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 ResultsMay 29, 2025 | msn.comMillennium Management LLC Has $7.40 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML)May 28, 2025 | marketbeat.comLeerink Partnrs Comments on Tourmaline Bio FY2026 EarningsMay 27, 2025 | marketbeat.com29,844 Shares in Tourmaline Bio, Inc. (NASDAQ:TRML) Purchased by Rafferty Asset Management LLCMay 25, 2025 | marketbeat.comBMO Sees Overreaction, Maintains Rating and Price Target on Tourmaline Bio (TRML)May 23, 2025 | msn.comWexford Capital LP Purchases New Position in Tourmaline Bio, Inc. (NASDAQ:TRML)May 22, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Stake Increased by Velan Capital Investment Management LPMay 21, 2025 | marketbeat.comTourmaline Bio posts mid-stage data for anti-inflammatory agentMay 20, 2025 | msn.comTourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 InhibitionMay 20, 2025 | seekingalpha.comTourmaline Bio to Present Topline Results from the Ongoing Phase 2 TRANQUILITY Trial of Pacibekitug on May 20, 2025May 19, 2025 | globenewswire.comAnalysts Set Expectations for Tourmaline Bio FY2025 EarningsMay 10, 2025 | marketbeat.comLeerink Partnrs Comments on Tourmaline Bio FY2025 EarningsMay 10, 2025 | marketbeat.comBrokers Set Expectations for Tourmaline Bio FY2025 EarningsMay 9, 2025 | marketbeat.comQ2 EPS Estimates for Tourmaline Bio Decreased by AnalystMay 9, 2025 | marketbeat.comLeerink Partnrs Weighs in on Tourmaline Bio Q2 EarningsMay 9, 2025 | marketbeat.comAlyeska Investment Group L.P. Lowers Position in Tourmaline Bio, Inc. (NASDAQ:TRML)May 9, 2025 | marketbeat.comHC Wainwright Weighs in on Tourmaline Bio Q2 EarningsMay 8, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Receives "Buy" Rating from HC WainwrightMay 7, 2025 | marketbeat.comTourmaline Bio's (TRML) "Buy" Rating Reiterated at Chardan CapitalMay 7, 2025 | marketbeat.comTourmaline Bio (TRML) Expected to Announce Earnings on MondayMay 7, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Barclays PLCMay 7, 2025 | marketbeat.comTourmaline Bio Reports Q1 2025 Financial ResultsMay 7, 2025 | tipranks.comSusquehanna Fundamental Investments LLC Invests $467,000 in Tourmaline Bio, Inc. (NASDAQ:TRML)May 6, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Issues Earnings ResultsMay 4, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Shares Purchased by Acuta Capital Partners LLCMay 4, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires 100,139 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)May 4, 2025 | marketbeat.comTourmaline Bio, Inc.: Tourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 3, 2025 | finanznachrichten.deTourmaline Bio Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 2, 2025 | globenewswire.comNantahala Capital Management LLC Lowers Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML)April 30, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML)April 30, 2025 | marketbeat.comTourmaline Bio, Inc. (NASDAQ:TRML) Position Trimmed by Marshall Wace LLPApril 29, 2025 | marketbeat.comChardan Capital Weighs in on Tourmaline Bio FY2025 EarningsApril 29, 2025 | marketbeat.comBlue Owl Capital Holdings LP Sells 451,080 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)April 26, 2025 | marketbeat.comTourmaline Bio (NASDAQ:TRML) Coverage Initiated at Chardan CapitalApril 25, 2025 | marketbeat.comTourmaline Bio initiated with a Buy at ChardanApril 23, 2025 | markets.businessinsider.comTourmaline Bio (TRML) Gets a Buy from Chardan CapitalApril 23, 2025 | markets.businessinsider.comChardan Capital Initiates Coverage of Tourmaline Bio (TRML) with Buy RecommendationApril 23, 2025 | msn.comNan Fung Group Holdings Ltd Acquires 40,290 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML)April 21, 2025 | marketbeat.comHere's Why We're Not Too Worried About Tourmaline Bio's (NASDAQ:TRML) Cash Burn SituationApril 19, 2025 | finance.yahoo.com Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Email Address TRML Media Mentions By Week TRML Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRML News Sentiment▼0.710.90▲Average Medical News Sentiment TRML News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRML Articles This Week▼53▲TRML Articles Average Week Get Tourmaline Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TRML and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tarsus Pharmaceuticals News Beam Therapeutics News Centessa Pharmaceuticals News Arcutis Biotherapeutics News Adaptive Biotechnologies News Immunocore News ARS Pharmaceuticals News Edgewise Therapeutics News Schrodinger News Biohaven News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRML) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tourmaline Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
